Azenta Inc at JPMorgan Healthcare Conference Transcript
Great. Thank you, everybody. My name is Casey Woodring from the Life Science Tools and Diagnostics team here at JPMorgan. I'm pleased to introduce our next presenting company, Azenta Life Sciences.
Joined with me here on stage is CEO, Steve Schwartz. Azenta is going to give a presentation, followed by a Q&A session. But with that, I'll just give it to Steve.
Great. Thanks, Casey, and good afternoon, everyone. I just want to start with -- I'm here for the distance. I hope my voice will come along with me, so I apologize. But it's good to see everyone and Casey, we're delighted to be here at the JPMorgan conference. So we really appreciate the invitation and the opportunity to present.
As Casey mentioned, I'm Steve Schwartz. I'm the CEO of Azenta Life Sciences. We've been -- Azenta now is a stand-alone life sciences company for a year. So we just passed our 1-year anniversary as a stand-alone
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |